Home › Kanser sa Dugo › Michigan › Detroit
Pag-aaral pangklinika para sa Kanser sa Dugo sa Detroit, MI
Isang pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Detroit. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Nagre-recruitPhase 3
- Children's Hospital of Michigan, Detroit
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Nagre-recruitObservasyonal na pag-aaral
- Henry Ford Health Saint John Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Nagre-recruitPhase 3
- Karmanos Cancer Institute ( Site 0047), Detroit
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
- Wayne State University School of Medicine, Detroit
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer Institute, Detroit
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Nagre-recruitPhase 2
- Barbara Ann Karmanos Cancer Institute, Detroit
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Michigan, Detroit
- Henry Ford Health System, Detroit
Increasing Knowledge and Interest in Cancer Clinical Trials
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Wayne State University/Karmanos Cancer Institute, Detroit
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Nagre-recruitPhase 2
- Henry Ford hospital, Detroit
Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic Impairment
Nagre-recruitPhase 1
- Karmanos Cancer Institute, Detroit
Pag-aaral para sa Kanser sa Dugo sa ibang lungsod
- Houston, TX46 pag-aaral
- New York City, NY26 pag-aaral
- Boston, MA25 pag-aaral
- Washington, DC19 pag-aaral
- Baltimore, MD18 pag-aaral
- Seattle, WA18 pag-aaral
- Los Angeles, CA17 pag-aaral
- Durham, NC16 pag-aaral
- Chicago, IL15 pag-aaral
- Philadelphia, PA14 pag-aaral
- Columbus, OH14 pag-aaral
- Edison, NJ13 pag-aaral
Iba pang pag-aaral sa Detroit
- Non-Small Cell Lung Cancer44 pag-aaral
- Kanser sa Suso34 pag-aaral
- Kanser (lahat ng uri)29 pag-aaral
- Colorectal Cancer26 pag-aaral
- Kanser sa Ovary26 pag-aaral
- Metastatic Cancer24 pag-aaral
- Kanser sa Prostate22 pag-aaral
- Kanser ng Endometrium21 pag-aaral
- Kanser sa Baga20 pag-aaral
- Multiple Myeloma19 pag-aaral
- Kanser sa Tiyan16 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 7, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.